Radiation Oncology/Therapy: Page 200

Low-dose mammo, wireless US probe, 3T MRI pace Siemens at RSNA
By Wayne Forrest, Brian Casey
CHICAGO - A new digital mammography system with lower radiation dose, a wireless ultrasound probe, a 3-tesla MRI scanner designed for high-performance clinical and research work, and a new line of angiography systems are among the highlights in the RSNA 2012 booth of Siemens Healthcare.
November 27, 2012
2012 11 28 11 37 26 607 Siemens Mammomat Prime Thumb
Study shows PET/CT lights up 'chemo brain' regions
By Edward Susman
CHICAGO - Researchers utilizing F-18 FDG PET/CT imaging have found that women who express "chemo brain" symptomology appear to have sharply reduced glucose metabolism in critical areas of the brain. Results from the study were presented on Tuesday at the RSNA meeting.
November 27, 2012
ClearCanvas teams with MGH on tumor imaging metrics system
By AuntMinnie.com staff writers
PACS/RIS developer ClearCanvas has announced the integration between its open-source PACS and workstation and the Tumor Imaging Metrics Core (TIMC) clinical trials system developed at Massachusetts General Hospital (MGH).
November 26, 2012
Australians tackle challenge of designing low-cost RT system
By Cynthia E. Keen
CHICAGO - An Australian research team has designed a compact radiotherapy (RT) system intended to lower the costs of building and operating a radiotherapy center. The goal is to reduce a known global shortage of radiotherapy, especially in countries with challenged economies.
November 24, 2012
Philips reaches Ambient Experience milestone
By AuntMinnie.com staff writers
Philips Healthcare has received the 500th order for its Ambient Experience design.
November 19, 2012
Polymers could ease brachytherapy seed delivery
By Cynthia E. Keen
Surgical implantation and removal of radioactive seeds is required for brachytherapy cancer treatment. Use of polymers may eliminate the need for this invasive procedure when treating solid tumors, according to data published in the November 15 issue of Cancer Research.
November 15, 2012
New 'LUNG-RADS' scheme sorts out screening results
By Eric Barnes
Thursday, November 29 | 11:40 a.m.-11:50 a.m. | SSQ10-08 | Room S403AA new "LUNG-RADS" system for lung cancer screening with CT aims to standardize the reporting of findings, both pulmonary and extrapulmonary, according to researchers from the Lahey Institute in Burlington, MA, who developed the system late last year.
November 15, 2012
Lesion-tracking tool reduces errors and increases efficiency
By Cynthia E. Keen
Tuesday, November 27 | 3:20 p.m.-3:30 p.m. | SSJ13-03 | Room S402ABAn annotation and image markup lesion-tracking tool measuring changes in size, or lack thereof, in tumors shown on diagnostic imaging exams of cancer patients is producing significant improvements in oncologic lesion measurement efficiency, as well as reductions in documentation errors, at the University of Chicago.
November 15, 2012
Lesion-tracking tool boosts efficiency in RECIST assessments
By Erik L. Ridley
Monday, November 26 | 11:10 a.m.-11:20 a.m. | SSC08-05 | Room S402ABA study team will describe how an automated lesion-tracking tool improves radiologist efficiency for quantitative assessment of cancer response on CT studies.
November 15, 2012
DCE- and DWI-MRI show neoadjuvant chemotherapy results in breast cancer
By Wayne Forrest
Tuesday, November 27 | 11:10 a.m.-11:20 a.m. | SSG01-05 | Arie Crown TheaterBoth dynamic contrast-enhanced (DCE) and diffusion-weighted (DWI) MRI can accurately reflect response to neoadjuvant chemotherapy among breast cancer patients during treatment with minimum apparent diffusion coefficient (ADC) as the most predictive marker of pathologic response, according to a study to be presented on Tuesday.
November 14, 2012
US, MRI tumor measurements can predict residual disease
By Kate Madden Yee
Sunday, November 25 | 12:30 p.m.-1:00 p.m. | LL-BRS-SU5A | Lakeside Learning CenterHow best can doctors assess residual disease in inflammatory breast cancer patients who have undergone neoadjuvant chemotherapy? Find out in this Sunday poster presentation.
November 13, 2012
FDG-PET/CT works for primary breast cancer staging
By Kate Madden Yee
Sunday, November 25 | 11:15 a.m.-11:25 a.m. | SSA18-04 | Room S505ABFDG-PET/CT may be used as primary staging modality in patients with primary breast cancer, according to this Sunday morning presentation to be given by German researchers.
November 13, 2012
Previous Page
Page 200 of 467
Next Page